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XRN1 is a 5′ → 3′ processive exoribonuclease that degrades mRNAs after
they have been decapped. It is highly conserved in all eukaryotes, including
homologs in Drosophila melanogaster (Pacman), Caenorhabditis elegans (XRN1), and
Saccharomyces cerevisiae (Xrn1p). As well as being a key enzyme in RNA turnover,
XRN1 is involved in nonsense-mediated mRNA decay and degradation of mRNAs
after they have been targeted by small interfering RNAs or microRNAs. The
crystal structure of XRN1 can explain its processivity and also the selectivity
of the enzyme for 5′ monophosphorylated RNA. In eukaryotic cells, XRN1 is
often found in particles known as processing bodies (P bodies) together with
other proteins involved in the 5′ → 3′ degradation pathway, such as DCP2 and
the helicase DHH1 (Me31B). Although XRN1 shows little specificity to particular
5′ monophosphorylated RNAs in vitro, mutations in XRN1 in vivo have specific
phenotypes suggesting that it specifically degrades a subset of RNAs. InDrosophila,
mutations in the gene encoding the XRN1 homolog pacman result in defects in
wound healing, epithelial closure and stem cell renewal in testes. We propose a
model where specificmRNAs are targeted to XRN1 via specific binding of miRNAs
and/or RNA-binding proteins to instability elements within the RNA. These guide
the RNA to the 5′ core degradation apparatus for controlled degradation.  2012 John
Wiley & Sons, Ltd.
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INTRODUCTION
Control of the flow of information from genes toproteins is vital for any organism, and regulation
of gene expression has been observed at almost
every level from initial transcription, through mRNA
processing and translation, to protein degradation.
The effect of controlled RNA turnover on gene
expression can be extremely significant: e.g., some
studies have shown that 40–50% of changes in
gene expression occur at the level of RNA stability.1
In multicellular organisms, it is increasingly evident
that degradation of specific mRNAs is critical for
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the regulation of many cellular processes, including
early development, infection and inflammation,
apoptosis, and aging.2,3 For example, in mice deficient
for the RNA-binding protein tristetraprolin (TTP),
the stabilities of mRNAs such as tumor necrosis
factor-α increase, resulting in a systemic inflammatory
syndrome with autoimmunity and bone marrow
overgrowth.4 In contrast, knockdown of the RNA-
binding protein HuR (related to the Drosophila
protein ELAV) destabilizes GATA-3, leading to
reduced cytokine secretion.5 Therefore transcript
degradation can be selective and also modulated,
suggesting a little studied layer of control of gene
expression affecting cellular processes.
The RNA degradation machinery is also inti-
mately linked to other critical cellular and regulatory
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FIGURE 1 | XRN1 is highly conserved between Drosophila melanogaster and Homo sapiens and is similar to XRN2 in the nuclease domain (green
area), particularly within the two conserved regions (CR1 and CR2, orange areas). Four domains have been identified in the central region of
D. melanogaster Pacman12 that are not present in XRN2, but can be found in H. sapiens XRN1. Amino acid sequences of the protein domains were
compared using Vector NTI Advance 11 (Invitrogen, Carlsbad, California) with the percent similarity shown together with the percent identity (in
parenthesis).
processes such as protein translation, nonsense-
mediated mRNA decay (NMD), RNA interference,
and regulation via microRNAs (miRNAs).2,3 For
example, translational repression followed by tran-
script degradation is an important control mechanism
during specification of the body plan in Drosophila
and during axon guidance in humans. The molecular
mechanisms of nonsense-mediated decay, where aber-
rant transcripts containing a premature stop codon are
degraded, require the recruitment of the core RNA
degradation machinery. In addition, knockdown of
gene expression by RNA interference or miRNAs
utilizes core RNA degradation pathways to elimi-
nate target RNAs.6,7 Therefore, understanding the
molecular mechanisms governing mRNA stability of
particular transcripts may also provide insights into
other important post-transcriptional processes.
In this review, we aim to outline the mecha-
nisms of mRNA degradation in eukaryotes and then
focus on XRN1, the critical exoribonuclease in the
5′ → 3′ degradation pathway. Recent advances in the
understanding of the structural properties and biolog-
ical roles of XRN1 in a number of organisms will
be discussed with particular focus on Pacman, the
Drosophila melanogaster homolog. We suggest that
XRN1 is involved in the specific targeting of partic-
ular transcripts involved in development and outline
possible mechanisms for this targeting process.
5′ → 3′ EXORIBONUCLEASE
CONSERVATION, STRUCTURE,
AND MECHANISM OF ACTION
The two main 5′ → 3′ exoribonucleases found
in eukaryotes are XRN1 (Pacman) and XRN2
(Rat1). Rat1 is located in the nucleus and is
involved in ribosomal RNA maturation,8 tran-
scription termination,9 and telomere maintenance.10
XRN1 is predominantly cytoplasmic and is required
for the processive degradation of 5′ monophospho-
rylated RNA, such as decapped or cleaved mRNA.
Decapped RNA is produced during the normal
turnover of mRNA in the cytoplasm, whereas cleaved
RNA occurs during RNA interference, degradation
via miRNAs and in NMD.6 XRN1 and 2 show high
sequence homology in the N-terminal region, within
which the RNAse domain is located. There is extensive
conservation of the XRN1 N-terminal region across
eukaryotes, with greater variation in the C-terminal,
which is the segment absent in XRN2 (Figure 1).
The first structural determination of an XRN-
type molecule was performed on XRN2/Rat1
from Schizosaccharomyces pombe, complexed to its
binding partner Rai1. The two well conserved regions
in Rat1 form a single domain, of which CR1 forms
the active site which CR2 surrounds, facilitating
exonuclease activity. Rai1 associates with a poorly
conserved region on the C-terminal side of CR2,
conferring stability to Rat1 and enhancing its ability
to degrade structured RNA.11
More recently, the structure of XRN1 has
been determined in two organisms, D. melanogaster
(Pacman)12 andKluyveromyces lactis.13 TheCR1/CR2
domain containing the active site in XRN1 is sim-
ilar to that of XRN2, but the large C-terminal
of XRN1 is not present in XRN2 (Figure 1). The
domains adjacent to CR1/CR2 have been character-
ized as single PAZ/Tudor, KOW, Winged helix, and
SH3-like domains12; in K. lactis four domains (D1–4)
were identified with similar β-barrel structures.13 The
remaining C-terminal region was not crystallized, pre-
sumably because it was relatively unstructured.
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The nuclease domain, within the N-terminus
of XRN1, is able to degrade decapped (5′ mono-
phosphorylated) RNA. The 5′ phosphate is recognized
by a basic pocket formed by four highly conserved
residues (Lys93, Gln97, Arg100, and Arg101 in
Pacman), from which larger 5′ groups are steri-
cally excluded. This explains why XRN1 cannot
degrade capped RNA. A helix, known as the tower
domain, makes contact with the substrate via His41
and Trp540 and facilitates directional processivity
using a ratchet-like mechanism. Therefore the struc-
tural characteristics largely explain the specificity of
Xrn1/Pacman for 5′ monophosphorylated RNA (or
single-stranded DNA14) together with its processivity.
The PAZ/Tudor domain primarily plays a structural
role in Xrn1, stabilizing the structure of the catalytic
domain, in an analogous manner to the function of
Rai1 in stabilizing Rat1. Various deletions or sub-
stitutions in the unstructured C-terminus of Pacman
or K. lactis XRN1 have been shown to impair nucle-
ase activity or affect protein stability, highlighting
the requirement of the C-terminal region for XRN1
function, despite its lower conservation compared to
the N-terminus. This corresponds with biological evi-
dence where mutations to the C-terminal of XRN1
are detrimental or are unable to rescue the pheno-
types of XRN1 null yeast.14 In D. melanogaster, the
unstructured C-terminal domain includes a polyglu-
tamine repeat, which may act as a scaffold to organize
other proteins around it.15
In vitro, it has been shown that stable secondary
structures, such as extensively base-paired stem loops
or G4 tetraplexes can stall the processivity of Xrn1.
Although XRN1 has been implicated in G4-tetraplex
binding and cleavage,16 it seems more likely that these
observations can be explained by XRN1 degrading the
RNA probes up to the G4 tetraplex and then stalling
at the stable G4-tetraplex structure. XRN1 appears
to be able to degrade structured RNA by pulling the
RNA through a channel that is wide enough for only
a single strand, which causes duplex unwinding.12
However, it cannot at present be ruled out that the
unstructured C-terminal domain also plays a role
in RNA unwinding, either by itself or by recruiting
another protein (Box 1).
DEGRADATION PATHWAYS
IN EUKARYOTES
How does XRN1 contribute to mRNA turnover in
vivo? To answer this question we must understand
the eukaryotic mRNA degradation pathways, which
are complex and nonlinear. Since actively translating
mRNAs are normally held in a circular conformation,
BOX 1
DOES A CYTOPLASMIC XRN2 HOMOLOG
REPLACE XRN1 IN PLANTS?
No XRN1 homolog is encoded by Arabidopsis
thaliana or other higher plant species. A number
of XRN2 homologs are present, however, two of
which are nuclear (AtXRN2/3) and one which is
cytoplasmic (AtXRN4).17 AtXRN2/3 degrade loops
excised from miRNA precursors18 and AtXRN2,
like XRN2/Rat1, is involved in rRNA processing.19
Despite being more closely related to XRN2
than XRN1, the cytoplasmically located AtXRN4
appears to be at least partially a substitute for
XRN1. It is not an essential protein, but like
XRN1, AtXRN4 degrades the 3′ fragment created
after miRNA-induced cleavage of mRNAs,20 and
decapped transcripts accumulate when AtXRN4
is mutated.21 It has recently been shown that the
AtXRN4 discriminates between 3′ fragments cre-
ated by miRNA induced cleavage, as only a selec-
tion accumulate in mutants.20 Atxrn4 mutant
plants lack any apparent visible phenotype but
were found to be ethylene insensitive as a con-
sequence of the upregulation of EIN3-binding
F-box protein1 (EBF1) and EBF2 mRNA levels,
encoding related F-box proteins involved in the
turnover of EIN3 protein, a crucial transcriptional
regulator of the ethylene response pathway.22
decircularization of transcripts is the first step in ren-
dering them susceptible to degradation. This can occur
in three ways (Figure 2). For normal mRNAs, dead-
enylation is typically the first step, where the poly-A
tail of the transcript is removed to allow access for
the exosome, a large complex responsible for 3′ → 5′
degradation.2 Alternatively, the decapping enzymes
may first decap the RNA. After decapping, which com-
monly but not exclusively occurs after deadenylation,
the transcript is vulnerable to 5′ → 3′ degradation
by XRN1.2,3 Finally, transcripts can be internally
cleaved, producing two products, each of which is
vulnerable to degradation by the exosome or by
XRN1. Each step of the mRNA degradation pathway
is described in detail below.
Decapping
The best characterized decapping enzyme is Dcp2,
which functions together with the decapping activa-
tor Dcp1 to remove the 7-methylguanylate cap by
hydrolysis.23 More recently, Nudt16, an alternative
decapping enzyme, has been identified in mammalian
cells.24 Both Dcp2 and Nudt16 can show specificity
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FIGURE 2 | Overview of the three pathways used in eukaryotes for mRNA degradation. The circular conformation of mRNA due to the 5′ cap
interacting with the 3′ poly-A tail can be disrupted by removal of the 5′ cap (decapping), removal of the 3′ poly-A tail (deadenylation), or by
endonucleolytic cleavage (e.g., due to RNAi, or nonsense-mediated mRNA decay in some organisms). Decapping exposes the mRNA to degradation
by the 5′ → 3′ exoribonuclease XRN1 (Pacman) and deadenylation allows access for 3′ → 5′ degradation by the exosome complex. Cleavage
creates two fragments, each of which is susceptible to either XRN1 or the exosome.
for particular transcripts or can act redundantly.25
While Nudt16 is ubiquitously expressed in mam-
malian cells, Dcp2 is more restricted in its expres-
sion, being absent from certain tissues such as heart,
liver, and kidney. There are no obvious homologs
for Nudt16 in yeast, Caenorhabditis elegans or
Drosophila.24 After cap removal, the mRNA bear-
ing a 5′ monophosphate is vulnerable to degradation
by XRN1. In vivo, decapping predominately occurs
after deadenylation, but has also been found to occur
independently of deadenylation for some transcripts,
e.g., yeast EDC1 mRNA.26
ARE-Mediated Decay
AU-rich regions often occur within the 3′ UTR of
short-lived mRNAs involved in the inflammatory
or stress response (e.g., GM-CSF, c-fos, and c-
myc). These AU-rich regions have been identified
as binding sites for mRNA-binding proteins (like
TTP) that can promote transcript degradation by
recruitment of the CCR4–NOT complex resulting
in deadenylation of the mRNA and subsequent
decapping and degradation of the mRNA by
XRN1.4,27 TTP (as well as BRF proteins) can localize
ARE-mRNAs to processing bodies (P bodies; see
below), particularly when RNA decay enzymes like
XRN1 are limiting.28
miRNA-Mediated Decay
miRNAs are key regulatory molecules which specif-
ically repress protein expression from their target
mRNAs. In plant cells, where miRNAs are typically
fully complementary to their targets, it is established
that binding of miRNAs to their target sequences can
result in cleavage of the target transcript by Argonaute
proteins and subsequent degradation of the 3′ and 5′
sections by AtXRN4 and the exosome, respectively.
However, miRNA-mediated translational repression
or deadenylation followed by decapping may also
occur.29 In animal cells, the mechanisms of miRNA-
mediated gene silencing are not clear and may involve
a variety of mechanisms, depending on the specific
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target or cell type. Recent work shows that degra-
dation of miRNA targets, rather than translational
repression alone, is a widespread effect of miRNA-
based regulation, and accounts for most of the repres-
sion mediated by miRNAs in cell cultures.29 Although
miRNAs can direct endonucleolytic cleavage of fully
complementary target transcripts (e.g., HOXB8), this
appears to be rare in animal cells, where miRNAs are
usually partially complementary to their targets. For
these targets, miRNAs usually direct their targets to
the 5′ → 3′ mRNA pathway, where transcripts are
first deadenylated by the CAF1–CCR4–NOT dead-
enylase complex, then decapped by the decapping
complex and finally degraded by XRN1. However,
it is at present unclear whether decay results from
an initial block in translation or through another
regulatory pathway, which may be transcript spe-
cific or dependent on the cell type (see Refs 29 and
30 for review). Yet another recent model for miRNA-
mediated degradation is miRNA cleavage of the target
mRNA followed by addition of an oligo U tract at the
3′ end of the 5′ fragment. 3′ U tracts can stimulate 5′
decapping, and inhibit 3′ → 5′ degradation, leading
to 5′ → 3′ degradation of the 5′ section of the RNA.31
Small Interfering RNAs-Mediated mRNA
Decay
RNA interference requires the binding of fully
complementary small interfering RNAs, or longer
antisense RNAs (in the case of C. elegans and
D. melanogaster) to the cytoplasmic mRNA target.
This binding guides the endonucleolytic cleavage
of the target transcript by Ago2 and subsequent
degradation of the cleavage products by Xrn1 and
the exosome.30
Nonsense-Mediated mRNA Decay
NMD is a RNA quality mechanism which removes
aberrant mRNAs that bear Premature Termination
Codons (PTCs) or unusually long 3′ UTRs. This is
important as it prevents the synthesis of truncated
proteins which could be detrimental to the cell. The
mechanism ofNMDdiffers between yeast,Drosophila
and metazoans, depending on their complement of
Smg proteins.32 In D. melanogaster, which has
Smg6 but lacks Smg7, NMD occurs exclusively by
Smg6-directed cleavage of the transcript near the
PTC followed by degradation of the two cleavage
fragments by Xrn1 and the exosome.33,34 In humans,
NMD appears to proceed either by SMG-mediated
endocleavage35 or by exonucleolytic decay from either
end (see Ref 32 for review) (Box 2).
BOX 2
miRNA DEGRADATION BY XRN1?
Overwhelmingly, research into miRNAs has
focused on their biological roles and mecha-
nism of action. Relatively little has addressed
the question of how miRNAs themselves are
degraded, either at the end of their lives or
for regulatory purposes. As miRNAs act cytoplas-
mically, the 5′ → 3′ or 3′ → 5′ RNA degradation
pathways are the obvious candidates responsi-
ble for degradation of miRNAs. Recent work
has suggested that in the case of the unstable
human miR-382, both the exosome and XRN1
are involved in its turnover, with the exosome
playing a more significant role than XRN1, and
with no contribution by XRN2.36 Contrary to this,
work in Caenorhabditis elegans on a mutant
miR-let-7 has indicated that it is XRN2 that is
responsible for its degradation, with XRN1 mak-
ing no contribution.37 A further study has shown
depletion of either XRN1 or XRN2 can lead to
the accumulation of some, but not all miRNA*
‘passenger strands’, such as miR-58* and miR-
73*, but not miR-let-7*.38 In addition, ‘Small
Degrading Nucleases’ have been identified as
the enzymes that degrade miRNAs in Arabidop-
sis,39 rather than the cytoplasmic XRN (AtXRN4),
which is more closely related to XRN2/Rat1 than
to XRN1. The breadth of data concerning this
question is currently too limited to draw firm
conclusions about the level of involvement of
XRN1, or indeed XRN2, the exosome or other
nucleases in degradation of miRNAs.
LOCALIZATION OF XRN1
IN EUKARYOTIC CELLS
XRN1 and other RNA degradation factors vary in
cellular location under different conditions and in
different cell types, but XRN1 and the exosome
do not colocalize in the cytoplasm of cells. XRN1
can be spread diffusely across the cytoplasm, or
found localized in P bodies, alongside other proteins
that allow for deadenylation, decapping, and 5′ → 3′
degradation of mRNAs. The localization of XRN1 to
discrete cytoplasmic foci was first noted in a mouse
fibroblast cell line,16 and subsequent studies described
how other degradation factors such as DCP1/2 and
LSM1-7 colocalized in the same particles, leading
to the idea that P bodies were the site of mRNA
degradation.3,40 Consistent with this was evidence
that showed P bodies appearing or increasing in size in
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situations where there is a build up of translationally
repressed mRNAs, like during heat shock,41 when
XRN1 function is reduced, such as inD. melanogaster
or yeast XRN1 mutants,42,43 or in human cells with
XRN1 depleted.40 Reducing the amount of repressed
mRNA by reducing the rate of transcription results
in a reduction in size and number of P bodies, as
does inhibiting deadenylation of mRNAs.43 However,
it is possible for mRNAs to leave P bodies and
regain translational activity44 and for degradation
to occur without P-body formation.45,46 This suggests
that P bodies, rather than being straightforward RNA
recycling centers, act as storage sites for translationally
inactive mRNAs, where mRNAs can be degraded or
released as required.
Numerous proteins are present alongside XRN1
in P bodies, with the composition varying between
organisms and cell types. The deadenylases such
as PAN2/3, CAF1, and CCR4, and the associated
NOT complex are present in P bodies and first
remove the poly-A tail of the mRNA to allow
access for the LSM1-7 complex of proteins that bind
deadenylated mRNA. The LSM proteins recruit the
decapping enzyme DCP2 and its associated factors
such as DCP1, PAT1, and EDC3 to remove the 5′
m7G cap from the mRNA, and the helicase DHH1
(Me31B in D. melanogaster) to enhance unwinding
of the mRNA to allow XRN1 access (reviewed in
Refs 27 and 47). Factors involved in NMD, such
as the UPF and SMG proteins48,49 and transcripts
targeted by the RNA-induced silencing complex
(RISC) also accumulate in P bodies.50 EDC3, PAT1,
and LSM4 have been identified as P-body scaffolding
proteins required for the recruitment and nucleation
of mRNA and other factors.51 XRN1 itself has been
found to associate with LSM2/4/8,52 PAT1,53 and
UPF1/2/3A.54
Other RNA granules found within cells contain
freshly transcribed mRNAs and co-ordinate localized
translation (e.g., germinal granules or neuronal
granules), and others process mRNAs released from
polysomes (P bodies, as previously described, and
stress granules).55 Stress granules form in response
to stress and differ slightly in composition from
P bodies, most notably as they contain translation
initiation factors and the small ribosomal subunit
(see Ref 56 for review). They contain XRN1, but
do not contain DCP1/2. Stress granules allow cells
to change their translational output in times of
stress by aggregating mRNAs not required for the
stress response, to allow preferential translation of,
e.g., heat shock proteins. Again, however, they are
not simple storage sites of mRNAs and initiation
factors, as mRNA and protein association can be
transient, and mRNAs can be shuttled between stress
granules and P bodies.41 The role of XRN1 in stress
granules is not immediately obvious, as they lack
DCP1/2, the action of which is required for XRN1
degradation. However, the RISC is present in stress
granules, which may produce a substrate for XRN1 if
cleavage/degradation does indeed occur within stress
granules.
Neuronal granules are related to P bodies, as they
contain DCP1/2 and XRN1, and to stress granules,
as translation initiation factors and the small riboso-
mal subunit are present. They also contain the large
ribosomal subunit, NMD/RISC proteins, and trans-
lationally repressed mRNAs.55,57 Neuronal granules
are transported to the synapses of dendrites, where
they function to change the local translational profile
on stimulation. This involves release of the ribosomes,
initiation factors and mRNA to form polysomes and
may entail degradation and/or translational repres-
sion of other mRNAs, as all the machinery required is
present (i.e., DCP1/2, XRN1, RISC, etc.).
FUNCTION OF XRN1 IN VIVO
To understand the biological function of XRN1
in vivo, the phenotypes of mutations to XRN1
genes have been studied in a variety of organisms,
particularly Saccharomyces cerevisiae,C. elegans, and
D. melanogaster. The phenotypes observed in various
organisms are summarized later.
Phenotypes of XRN1Mutations
in Unicellular Organisms
The earliest phenotypic studies on XRN1 were per-
formed in the yeast S. cerevisiae. Mutations in XRN1
resulted in a number of phenotypes suggesting that
XRN1 had a number of different functions. As a
consequence, XRN1 has been referred to by a num-
ber of names (Table 1). Disruption of XRN1 was
first shown to decrease growth rate by more than
50%.58 Around the same time, XRN1 was identi-
fied in a screen for genes that enhance the nuclear
fusion defect phenotype of kar1-1 mutants.59 kar1-1
populations form diploids at a lower frequency than
wild type and three genes were found in a mutagen-
esis screen that further reduced the rate of diploid
formation; these were referred to as KEM1-3, of
which KEM1 was later found to encode the same
gene as XRN1. The reduced rate of growth was again
noted for kem1 mutant strains, as well as inability
to sporulate and hypersensitivity to the microtubule
destabilizing compound benomyl (due to increased
chromosome loss in the mutant). XRN1 was further
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TABLE 1 List of Phenotypes Observed for XRN1 Mutations and Associated Gene Names in Various Organisms
Phenotype/Process Affected Organism XRN1 Gene Referred to as Reference
Reduced growth rate Saccharomyces cerevisiae XRN1 58
Nuclear fusion defect and chromosome loss S. cerevisiae KEM1 59
Defective sporulation and reduced recombination efficiency S. cerevisiae DST2/SEP1 60
Increased chromosome stability during mitosis S. cerevisiae RAR5 63
Increased cell size, variation in mRNA, and protein levels S. cerevisiae XRN1 61
Microtubule destabilization S. cerevisiae SEP1 64
Defects in filamentous growth S. cerevisiae KEM1 65
Defects in filamentous growth Candida albicans CaKem1 66
Failure of ventral enclosure Caenorhabditis elegans xrn1 67
Reduced growth rate Trypanosoma brucei XRNA 68
Ethylene insensitivity Arabidopsis thaliana AtXRN4 22
Epithelial sheet sealing Drosophila melanogaster pacman 69
Reduced male fertility/stem cell maintenance D. melanogaster pacman 42
Reduced female fertility/oogenesis D. melanogaster pacman 70
Degradation of long, non-coding RNAs (XUTs) S. cerevisiae XRN1 62
Increased half life of short-lived mRNAs T . brucei XRNA 71
named DST2 as DNA-strand transfer (spontaneous
mitotic recombination) was found to be markedly
reduced in mutants, and also referred to as strand
exchange protein 1 (SEP1) for the same reason.60
Further work found that xrn1 mutant cells were
larger than wild-type cells, with a reduced protein
and rRNA synthesis rates but higher protein levels.
The half lives of specific mRNAs were also found to
be increased, and it was postulated that the pleiotropic
nature of these mutations may be due to the variation
in levels of mRNAs and their protein products, rather
than XRN1 physically performing multiple functions
itself.61 More recently, XRN1 has been implicated
in the degradation of long, antisense non-coding
RNAs (XRN1-sensitive unstable transcripts—XUTs).
RNA-seq has been used to identify over 1600 XUTs,
the majority of which are antisense to open-reading
frames. In strains deficient for XRN1, XUTs accu-
mulate, and 273 genes have been identified with
reduced transcription due to the increase in antisense
XUTs.62
In the kinetoplastid parasite Trypanosoma
brucei, a transcriptome-wide study has shown that
XRNA, which is most similar to yeast and human
XRN1, is involved in the degradation of unstable
mRNAs with half lives of less than 30 min.
These include messenger RNAs encoding the RNA
degradation machinery (exosome, Lsm proteins),
nucleotide-binding proteins, and RNA methylases.71.
Previous work showed that downregulation of XRNA




Development of multicellular organisms requires intri-
cate, defined patterns of protein expression. Careful
modulation of the stability of mRNAs that encode
developmental proteins is essential to ensure their cor-
rect spatial and temporal expression. There are many
examples of organisms exploiting mRNA localiza-
tion, degradation, and translation to control protein
expression. As an exoribonuclease, XRN1 and its
homologs are obvious candidates to be involved
in rapid degradation of transcripts to prevent their
expression. Studies using multicellular organisms also
demonstrate that XRN1 can show specificity for
different transcripts resulting in particular pheno-
types. XRN1 phenotypes in metazoans are described
below; refer to Box 1 for XRN1 phenotypes in
plants.
This is illustrated by studies in the nematode
worm C. elegans, where the developmental pheno-
types resulting from downregulation of xrn1 show
that correct XRN1 function is a requirement for
post-transcriptional regulation of at least some tran-
scripts at certain stages of development. Our previous
work demonstrated that xrn1 is essential for ven-
tral enclosure,67 a process analogous to mammalian
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FIGURE 3 | xrn1 RNAi in Caenorhabditis elegans causes a lethal developmental phenotype. In wild-type embryos (a) ventral enclosure completes
after hypodermal cells migrate around and fuse on the ventral side. In xrn1 knockdown embryos (b), migration and sealing fail, which results in a
ventral hole.67
hind brain closure and wound healing, and dor-
sal closure and thorax formation in Drosophila.
Knockdown of xrn1 by RNAi causes the hypoder-
mal cells that would normally fuse on the ventral side
of the C. elegans embryo to fail to migrate and fuse
together, leaving a hole from which the internal cells
protrude67 (Figure 3).
In D. melanogaster, previous work from our
group using hypomorphic pcm mutations (Figure 4,
panel A) has revealed specific developmental and adult
phenotypes for pacman mutants.69 In these mutants,
the level of Pcm protein is reduced significantly
compared to wild type (Figure 4, panel B). The
level of pcm mRNA is reduced in the strongest
mutant, pcm5, by threefold but remains at wild-
type level for the weaker mutant pcm3 (Figure 4,
panel C). Processes that affect epithelial sheet sealing,
which is analogous to ventral enclosure in C. elegans,
are commonly affected in pcm mutants. During
development, defects have been observed during
dorsal closure in the embryo and thorax closure
during metamorphosis. During dorsal closure in wild-
type embryos, the two epithelial sheets move over
the amnioserosa and meet at the dorsal midline,
while in pcm mutants the epithelial cells either
do not move together, or fail to fuse, and spring
back. Thorax closure occurs during pupation as the
wing imaginal discs evert and grow toward each
other to fuse at the dorsal midline, and also fuse
to the leg imaginal discs.72 In some pcm mutants,
thorax fusion does not occur completely, and the fly
displays a cleft thorax phenotype (Figure 5, panels
A and B). A third phenotype related to epithelial cell
movement/sealing is that of impairedwound healing in
pcmmutants, which suffer from reduced survival after
wounding compared to wild-type controls.69 These
phenotypes are reminiscent of those seen for JNK
pathway mutants in D. melanogaster, such as kayak,
hemipterous, and puckered, where dorsal open and
cleft thorax phenotypes are common.72,73 A genetic
interaction between pcm and puckered is evident
in double mutants, as a bald patch appears at the
anterior of the dorsal midline.69 The wing imaginal
discs appear particularly sensitive to Pcm function,
as the effect is not limited to the parts of the discs
that form the thorax. The most penetrant phenotype
observed in hypomorphic pcm alleles presents in the
adult wings, which are frequently dull, lacking their
normal iridescence, and can be crumpled69 (Figure 5,
panels C and D).
A separate phenotype observed for hemizygotic
(male) pcm mutants is that of reduced fertility.42 The
strongest hypomorphic allele pcm5 produces half as
many offspring as wild-type controls. The testes of
pcm mutants are the same length as wild type, but
are noticeably thinner, by about 25% in pcm5 males
(Figure 6, panels A and B). The average number of
mature sperm present in the testes of 3-day-old pcm5
males upon dissection was around 3000, almost half
the number found in wild-type testes (Figure 6, panel
C). The number of sperm and offspring produced
by the weaker allele pcm3 were also reduced by
roughly a third each. In wild type, Pcm is expressed
most strongly in the spermatogonia and stem cells
at the tip of the testes, where the initial mitotic
divisions occur. Within these cells, Pcm localizes to
discrete cytoplasmic foci, determined to be P bodies
by colocalization with other P-body proteins, such as
Dcp1 and Me31B. Pcm is present at a greatly reduced
level in mutants such as pcm5 or pcm3, and no discrete
localization is obvious. However, staining for Dcp1
or Me31B shows an increase in size of the P bodies,
by up to 2.7-fold in pcm5.42
Pacman is similarly seen localized to P bodies in
female nurse cells, which are involved in oogenesis,
and within the egg itself.70 In pcm5 homozygotes
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(a)
(b) (c)
FIGURE 4 | (a) Hypomorphic pacman alleles were created by imprecise excision of the P-element P{EP}1526 in D. melanogaster. Red lines
represent deletions (516 bp in pcm5 and 1378 bp in pcm3). The red box for pcm5 represents a section of the pcm gene that is put out of frame by the
deletion. (b) The level of Pcm protein is reduced in both whole male and female adults for both pcm3 and pcm5, with the pcm5 level being almost
undetectable by Western blotting. However, genetic evidence shows the pcm5 allele is hypomorphic, so some partially functional protein must be
produced.69 (c) The expression of mRNA from the pcm gene in pcm5 and pcm3 was compared to the wild-type level in whole L3 larvae, using a
TaqMan quantitative Reverse Transcription Polymerase Chain Reaction (Applied Biosystems, Foster City, California) designed at the interface
between exons 3 and 4. The pcm mRNA in pcm3 (two biological replicates and six technical replicates) was the same as wild type, while the level in
pcm5 was reduced by threefold (three biological replicates and nine technical replicates, P < 0.001). Error bars show standard error of the mean.
(females), fewer eggs are produced compared to wild
type, and the number of offspring is markedly reduced
to just 7% of the wild-type level. In spermatogenesis
and oogenesis, the size of P bodies is increased in
the pcm mutant conditions, an effect often observed
when there is a build up of mRNAs that are not
being actively translated. In summary, mutations in
Xrn1/pacman result in specific phenotypes, suggesting
that it targets a specific set of mRNAs.
THE 5′ → 3′ AND 3′ → 5′
DEGRADATION PATHWAYS ARE NOT
REDUNDANT
Normal mRNA turnover in eukaryotes can proceed
from either end of the transcript, suggesting that the
5′ → 3′ degradation machinery should be able to com-
pensate if the 3′ → 5′ system is disrupted, or vice versa.
However, it is clear that the exosome is not capable
of compensating for XRN1 in multicellular organ-
isms such as C. elegans67 or D. melanogaster (Jones
and Newbury, unpublished data) as knockdown of
xrn1/pcm results in developmental failures and/or
lethality. This shows that each system is individu-
ally required for post-transcriptional gene regulation
of at least a subset of different transcripts. At the
molecular level, it is also clear that there is lack of
redundancy as the 3′ product of mRNA cleavage
(as a result of NMD or RISC activity) can only
be degraded by XRN1. When XRN1 is knocked
down by RNAi in D. melanogaster cell culture, the
3′ fragments of reporter mRNAs targeted by RNAi
accumulate, while 5′ fragments do not. Reciprocally,
knockdown of exosome subunits such as Ski2, Rrp4,
or Csl4, cause accumulation of the 5′ fragments, with
no effect on the 3′ fragments.6 We have recently
observed the same effect in D. melanogaster larvae
carrying a null pcm mutation and Adhfn6, an allele
of Alcohol dehydrogenase that undergoes NMD. In
the pcm and Adhfn6 double mutant, the 3′ fragment
of Adhfn6 mRNA accumulates (Jones and Newbury,
unpublished data). This apparent lack of redundancy




FIGURE 5 | Drosophila melanogaster pacman mutants display a
number of developmental phenotypes.69 (a) A wild-type fly thorax,
which forms as the wing imaginal discs grow together and fuse along
the dorsal midline during pupation. (b) A pcm5 fly displaying a ‘cleft
thorax’ phenotype where the wing imaginal disc cells have failed to
grow/migrate completely across the gap. (c) The wings of a wild-type fly
showing their natural iridescence. (d) A pcm5 fly with ‘dull’ wings that
lack iridescence.
between the 5′ → 3′ and 3′ → 5′ pathways can most
likely be explained by the fact XRN1 and the exosome
do not localize together. The 3′ fragment of Adhfn6
may never be released from P bodies as it is not a com-
petent mRNA (it has no cap) and therefore will never




In vitro, XRN1 is generally indiscriminate in
its degradation of 5′ monophosphorylated RNAs.
However, in vivo this is not the case as the
resulting phenotypes (detailed earlier) suggest that
certain transcripts are more susceptible to XRN1/Pcm
degradation than others. It has also been suggested
that the controlling step in 5′ → 3′ degradation, in
terms of specificity, is the decapping of transcripts.
However, the pools of transcripts upregulated in yeast
deficient for DCP1 or XRN1 are only 65% similar,
showing that degradation pathways controlled by
these enzymes are not identical.74 In addition, the
phenotypes ofDcp1mutants inDrosophila are not the
same as the phenotypes ofXRN1/pcmmutants.42,69,70
One explanation for this is that there are alternative
decapping enzymes in Drosophila which have not yet
been identified. Another explanation is that mRNAs
are specifically targeted to XRN1 and then XRN1
can recruit decapping enzymes (as well as other
factors) to degrade themRNA in the 5′ → 3′ direction.
A model to illustrate this hypothesis is given in
Figure 7.
For degradation of particular targets to take
place, specific mechanisms are required to target these
mRNAs to the core degradation machinery. The avail-
able evidence suggests that specific stability/instability
elements reside (usually) within the 3′ UTR of tran-
scripts. These sequence elements may be recognized at
the sequence level and/or may fold into particular sec-
ondary structures. A well-known example of an RNA
stability element is the AU-rich regions in the 3′ UTR
of short-lived cytokine and proto-oncogene RNAs (as
described earlier). Pyrimidine-rich regions of mRNA
3′ UTRs can also promote stability when bound by
poly(C)-binding proteins, and are often found in long-
lived transcripts.75 Examples of miRNAs targeting
the RISC to mRNAs via specific 3′ UTR sequences
to cause degradation or translational repression of
mRNAs have also been reported. A good example
concerns the repression of dLMO mRNA by miR-9a
during D. melanogaster wing development (see Ref 7
for review).
In our model (Figure 7), binding of miRNAs
and/or RNA-binding protein(s) to a specific instability
element results in assembly of the 5′ → 3′ degradation
complex. Pacman is recruited by this RNA-binding
protein and/or miRNA which in turn recruits and
activates the catalytic decapping protein Dcp2. The
addition of other decapping activators including
Me31B and Dcp1 completes the active complex and
the target is degraded. Since Pcm has a polyglutamine
repeat it is likely to assist in nucleation of P bodies.15
Presumably, this complex will need to be remodeled
to accept another mRNA for degradation. Our
laboratory is at present testing this hypothesis using
Drosophila as a model system.
CONCLUSION
The 5′ → 3′ exoribonuclease XRN1 was originally
thought to be a passive RNA disposal machine.
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(a)
(b) (c)
FIGURE 6 | pacman mutants display defects in testes morphology and sperm production. (a) The testes of young, hemizygous pcm5 and pcm3
males are significantly disrupted compared to wild type, due to a reduction in width (b). This results fewer sperm being produced (c).42
FIGURE 7 | Proposed model to explain degradation of specific transcripts by XRN1/Pacman. Transcripts targeted for degradation by the 5′ → 3′
pathway are bound by RNA-binding protein (purple) and/or a miRNA (black) at an RNA instability element (red) within the 3′ UTR. This results in
assembly of the 5′ → 3′ degradation complex. XRN1/Pacman (yellow) is recruited by the RNA-binding protein and/or the miRNA and in turn recruits
and activates the catalytic decapping protein Dcp2 (pink). The addition of other decapping activators including Me31B and Dcp1 completes the active
complex and the target is degraded.
However, our work, and that of others, show that
mutations in XRN1 or its homologs result in specific
phenotypes, suggesting that it normally degrades par-
ticular subsets of RNAs. In Drosophila, the mutant
phenotypes suggest that Pacman targets mRNAs
involved in stem cell function, cell proliferation, and
cell shape change. A key future priority is therefore
to identify these target mRNAs, as a first step in the
elucidation of the molecular mechanisms involved.
Since targeting of particular RNAs is likely to be tis-
sue specific, it will be preferable to carry out these
experiments in differentiated cells or to use model
organisms. Understanding the molecular processes
whereby mRNAs are targeted to the degradation
machinery may provide insights into means by which
mRNAs can be artificially targeted for degradation
in the cell. Since RNA degradation is intimately
linked with translation, these experiments may also
shed light on the links between degradation and
translation.
Another key consideration is the link between
the 5′ → 3′ degradation pathway and the 3′ → 5′
degradation pathway(s). Potential links have been
little studied in multicellular organisms, yet it is
possible that there may be interplay between these
pathways. It is also not yet clear how miRNA binding
directs the fate of its target mRNA toward degradation
or translational repression, or whether RNA-binding
proteins are also involved.7 Understanding the
molecular mechanisms underlying this process could
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be valuable in novel miRNA therapies. Finally, the sig-
nal which triggers mRNAs to stop translation and set
out on the degradation pathway is not at all clear.
Although the understanding of RNA degradation
pathways has improved greatly in recent years, there
is still much to be learned.
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